Business
OrganOx Completes Acquisition by Terumo Corporation to Advance the Future of Organ Transplantation
$1.5 billion acquisition strengthens global leadership in organ technology and accelerates progress toward making every organ countOXFORD, England and MADISON, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- OrganOx Ltd. today announced the completion of its acquisition by Terumo Corporation, following satisfaction of all customary regulatory and closing conditions. OrganOx is now a wholly owned subsidiary of Terumo, positioning the company to unlock new opportunities to evolve its technology and reach
About this update from Terumo Corporation
[{"type":"image","alt":"ORGANOX LIMITED","displaySize":"","headline":null,"caption":"ORGANOX LIMITED","className":"","disableSlideshowImg":false,"size":{"original":{"width":218,"height":52,"url":"https://media.zenfs.com/en/globenewswire.com/ca252a38aed1b30c38ede554d96340d5"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/pzw2VZ0iQqwoRO0awZuBlg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEwMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/ca252a38aed1b30c38ede554d96340d5","width":218,"height":52}},"lazy":false},{"type":"text","content":"$1.5 billion acquisition strengthens global leadership in organ technology and accelerates progress toward making every organ count","length":131,"tagName":"p"},{"type":"text","content":"OXFORD, England and MADISON, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- OrganOx Ltd. today announced the completion of its acquisition by Terumo Corporation, following satisfaction of all customary regulatory and closing conditions. OrganOx is now a wholly owned subsidiary of Terumo, positioning the company to unlock new opportunities to evolve its technology and reach more patients worldwide.","length":393,"tagName":"p"},{"type":"text","content":"As first announced on August 25, 2025, the acquisition combines OrganOx’s pioneering organ perfusion technology with Terumo’s global scale and expertise in medical innovation. “The global need for donor organs remains urgent, with thousands of patients each year dying while waiting for a transplant or facing the risk of a failed transplant,” said Craig Marshall, CEO of OrganOx. “Our mission has always been to create a world where every organ counts. Joining Terumo will accelerate our ability to scale our operations more rapidly, enter new markets and ensure that more patients around the globe can benefit from our technologies.”","length":635,"tagName":"p"},{"type":"text","content":"The acquisition will enable investment in research and development efforts, including the evolution of the OrganOx metra® platform technology beyond liver transplantation. It will also enable the company to capitalize on opportunities to expand the use of normothermic machine perfusion (NMP) for organ support and enhancement.","length":327,"tagName":"p"},{"type":"text","content":"In addition to advancing innovations, OrganOx will benefit from Terumo’s extensive global network to accelerate commercial expansion, deepen...